191 related articles for article (PubMed ID: 6383521)
1. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
[TBL] [Abstract][Full Text] [Related]
2. Early postnatal administration of 5,7-dihydroxytryptamine: effects on substance P and thyrotropin-releasing hormone neurons and terminals in rat brain.
Towle AC; Breese GR; Mueller RA; Hunt R; Lauder JM
Brain Res; 1986 Jan; 363(1):38-46. PubMed ID: 2418913
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
4. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
Hard E; Ahlenius S; Engel J
Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
[TBL] [Abstract][Full Text] [Related]
5. Changes in activity and mRNA for rat tryptophan hydroxylase and aromatic L-amino acid decarboxylase of brain serotonergic cell bodies and terminals following neonatal 5,7-dihydroxytryptamine.
Park DH; Stone DM; Baker H; Wessel TC; Kim KS; Towle AC; Joh TH
Brain Res; 1993 Apr; 609(1-2):59-66. PubMed ID: 8508321
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
[TBL] [Abstract][Full Text] [Related]
8. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
Pranzatelli MR; Dollison AM; Hlibczuk V
Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
[TBL] [Abstract][Full Text] [Related]
9. Supersensitivity of 5,7-dihydroxytryptamine-treated rats to the respiratory depressant and antitussive effects of dihydrocodeine.
Kamei J; Ogawa M; Kasuya Y
Eur J Pharmacol; 1988 Aug; 153(2-3):305-8. PubMed ID: 3181291
[TBL] [Abstract][Full Text] [Related]
10. Distribution of the radioactivity in the central nervous system of the developing rat following intracisternal or subcutaneous administration of 14C-5,7-dihydroxytryptamine.
Sievers J; Baumgarten HG; Klemm HP; Schlossberger HG; Lolova I
Bibl Anat; 1981; (19):302-7. PubMed ID: 7225075
[No Abstract] [Full Text] [Related]
11. Injection of 5,7-dihydroxytryptamine into the B3 raphe region of neonatal rat pups induces hyperalgesia but only slight alterations in ingestion-related behaviors.
Enters EK; Specht SM; Spear LP
Behav Neural Biol; 1990 Mar; 53(2):244-57. PubMed ID: 1691912
[TBL] [Abstract][Full Text] [Related]
12. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
Waller SB; Buterbaugh GG
Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
[TBL] [Abstract][Full Text] [Related]
13. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
[TBL] [Abstract][Full Text] [Related]
14. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
15. [Effects of intraventricular injection of 5,7-dihydroxytryptamine on monoamines and sleep in the kitten (author's transl)].
Adrien J; Bourgoin S; Laguzzi R; Hamon M
J Physiol (Paris); 1981; 77(2-3):425-30. PubMed ID: 7288656
[TBL] [Abstract][Full Text] [Related]
16. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
[TBL] [Abstract][Full Text] [Related]
17. Model of central chemical 'serotoninectomy' in mice.
Herman ZS; Bonczek A
Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
[TBL] [Abstract][Full Text] [Related]
18. Effect of 5,7-dihydroxytryptamine on the development of tolerance to ethanol.
Lê AD; Khanna JM; Kalant H; LeBlanc AE
Psychopharmacology (Berl); 1980 Feb; 67(2):143-6. PubMed ID: 6768090
[TBL] [Abstract][Full Text] [Related]
19. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.
Hrdina PD; Pappas BA; Bialik RJ; Ryan CL
Eur J Pharmacol; 1982 Sep; 83(3-4):343-4. PubMed ID: 7173315
[No Abstract] [Full Text] [Related]
20. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
Warbritton JD; Stewart RM; Baldessarini RJ
Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
